Abstract:The relationship between selenium and metabolic syndrome (MetS) has been discussed controversially, and limited studies have examined the associations of single nucleotide polymorphisms in selenoproteins genes with MetS. Hence, to examine the associations of plasma selenium concentrations and selenoprotein P rs7579 polymorphism with MetS, a case-control study of 1279 MetS cases and 1279 sex- and age- (+/- 2 years) matched controls was conducted based on the baseline data of the Tongji-Ezhou Cohort study. Plasma selenium concentrations were measured by inductively coupled plasma mass spectrometry. MetS was defined using the definition of the Joint Interim Statement, adjusted for the Chinese population. In addition, the rs7579 polymorphism was genotyped by the Agena MassARRAY System. Plasma selenium concentrations in the MetS group were higher than in the control group (93.88 mu g/L (83.17-107.41) vs. 92.66 mu g/L (82.36-103.53), P<0.05). Compared with quartile 4 (>= 103.53 mu g/L), the multivariate-adjusted odds ratios (ORs) and 95% confidence intervals (CIs) associated with MetS were 0.79 (0.59-1.06) for quartile 1 (mu g/L), 0.75 (0.56-1.01) for quartile 2 (82.37-92.66 mu g/L), and 0.61 (0.45-0.83) for quartile 3 (92.67-103.52 mu g/L). The cubic spline analyses revealed a U-shaped association between plasma selenium and MetS, with the lowest risk at around 93.69 mu g/L. Moreover, in cubic spline analyses, plasma selenium showed U-shaped associations with central obesity and high blood pressure, positive associations with hypertriglyceridemia and hyperglycemia, and a negative association with low high-density lipoprotein cholesterol. Additionally, both the GA and GA+AA genotype carriers were associated with increased ORs of MetS comparing with the GG genotype carriers. Our findings suggested a U-shaped association between plasma selenium and MetS and diverse associations between plasma selenium and components of MetS. Furthermore, our study found that the A allele of rs7579 was associated with higher odds of MetS. Further studies are needed to confirm our findings and elucidate the underlying mechanisms.

Unraveling the Link: Mendelian Randomization Reveals Causal Relationship Between Selenium and Metabolic Syndrome.

Tracing links between micronutrients and type 2 diabetes risk: the singular role of selenium

Genetic Association Between Circulating Selenium Level and the Risk of Schizophrenia in the European Population: A Two-Sample Mendelian Randomization Study

Mendelian randomization investigation highlights different roles of selenium status in mental disorders

Genetically determined selenium concentrations and risk for autoimmune diseases

Metabolic Syndrome and Risk of Colorectal Cancer: A Mendelian Randomization Study

A Mendelian randomization study between metabolic syndrome and its components with prostate cancer

Assessing Causal Estimates of the Association of Obesity-Related Traits with Coronary Artery Disease Using a Mendelian Randomization Approach

Appraising the Causal Association Between Systemic Iron Status and Heart Failure Risk: A Mendelian Randomisation Study

Genetically Predicted Selenium is Negatively Associated with Serum TC, LDL-C and Positively Associated with HbA1C Levels.

Mineral Metabolism and Polycystic Ovary Syndrome and Metabolic Risk Factors: A Mendelian Randomization Study

A Putative Causality of Vitamin D in Common Diseases: A Mendelian Randomization Study.

Diverse Associations of Plasma Selenium Concentrations and SELENOP Gene Polymorphism with Metabolic Syndrome and Its Components

The causal relationship between metabolic syndrome and its components and cardiovascular disease: A mendelian randomization study causal relationship between MetS and CVDs

The association between metabolic syndrome and lung cancer risk: a Mendelian randomization study

A new perspective on selenium’s impact on renal function: European population-based analysis of plasma proteome-mediated Mendelian randomization study

A new perspective on selenium's impact on renal function: European population-based analysis of plasma proteome-mediated Mendelian randomization study

Metabolic Disorders and Risk of Cardiovascular Diseases: a Two-Sample Mendelian Randomization Study

Genetic Prediction of Micronutrient Levels and the Risk of Colorectal Polyps: A Mendelian Randomization Study

Genetic prediction of the relationship between metabolic syndrome and colorectal cancer risk: a Mendelian randomization study

Causal relationship between metabolic syndrome and hidradenitis suppurativa: A two‐sample bidirectional Mendelian randomization study